Through this management of GLP-1 use, Excellus BCBS has realized cost savings, as indicated by the graph below: Excellus BCBS is using what appears to be the most sensible weight loss GLP-1 prior authorization criteria in the marketplace, without significantly disrupting rebates. -USI Partner What we know about the future of GLP-1 drugs In 2024, there were significant advancements with GLP-1 indications
GLP-1, or glucagon-like peptide one, is a drug class used to treat type 2 diabetes that may also result in weight loss
With consistent use, you may begin to notice results within 1 to 3 months
The compound is commonly requested by research institutions, analytical facilities, and documentation-focused laboratories that require traceable and well-defined compounds for experimental or comparative use
In practice a formulation trial is a pragmatic, individualized experiment rather than a proven fix
The treatment of choice for MNTI is excision, and it is usually curative